Position in AMGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$30,709,468
+$2,422,029 QoQ
Shares Held
87,280
+1.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 7%
Shared 0%
None 93%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MAI Capital Management holds $463,973,037 across 18 Drug Manufacturers - General names. AMGN ranks #5 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
548,990 | $134,195,115 | |
| 2 | ABBV |
AbbVie Inc.
|
577,833 | $125,672,899 | |
| 3 | LLY |
ELI LILLY & Co
|
96,089 | $88,379,779 | |
| 4 | MRK |
Merck & Co., Inc.
|
335,023 | $40,299,916 | |
| 5 | AMGN |
Amgen Inc
This page
|
87,280 | $30,709,468 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
223,761 | $13,571,104 | |
| 7 | PFE |
Pfizer Inc
|
420,692 | $11,813,031 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
44,349 | $6,180,920 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,709,468 | 87,280 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $28,287,439 | 86,424 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $21,811,520 | 77,291 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $19,720,881 | 70,631 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $22,244,046 | 71,398 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,512,216 | 71,026 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,705,062 | 39,431 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $14,151,797 | 45,293 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $13,014,463 | 45,774 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $11,186,984 | 38,841 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $10,433,800 | 38,822 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,495,151 | 38,263 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $9,523,499 | 39,394 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $10,830,485 | 41,237 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $9,403,913 | 41,721 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $7,840,342 | 32,225 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $8,093,957 | 33,471 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $7,858,652 | 34,932 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $15,630,412 | 73,503 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $17,147,812 | 70,350 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $17,496,816 | 70,322 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $19,056,689 | 82,884 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $20,636,775 | 81,196 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $19,182,729 | 81,331 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $16,098,992 | 79,411 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||